The Mind Research Network

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, The Mind Research Network sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).

17 total trials 4 currently recruiting 9 completed early-phase tilt top decile by trial count

The Mind Research Network: 17 sponsored US clinical trials, 4 recruiting.

The Mind Research Network sponsors 17 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 9 completed. 2 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Use Disorder, with 2 trials.

Top-decile sponsor footprint

The Mind Research Network ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 27/100

9 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

17 total, page 1 of 1

RECRUITING NA

Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders

NCT06981351

RECRUITING NA

The Synchrony Study: Examining Music Training for Children With FASD

NCT06005181

RECRUITING

Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

NCT05845333

RECRUITING Phase 2

A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol

NCT04770025

ACTIVE NOT RECRUITING NA

Brain Stimulation for Concussion

NCT05889117

COMPLETED NA

Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease

NCT05077826

TERMINATED Phase 2

Mechanisms of Lorcaserin for Smoking Cessation

NCT04396834

TERMINATED Phase 2

Laboratory Screening of Lorcaserin for Alcohol Use Disorder

NCT04396847

COMPLETED NA

Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder

NCT03829761

COMPLETED NA

Mindfulness for Alcohol Abusing Offenders

NCT03883646

TERMINATED Phase 2

Exploration of Gemfibrozil as a Treatment for AUD

NCT03539432

COMPLETED Phase 2

Modafinil for the Treatment of Alcohol Use Disorders

NCT03424681

COMPLETED NA

TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence

NCT02534454

COMPLETED NA

Cognitive Retraining and Brain Stimulation for Alcohol Use

NCT02045108

COMPLETED Phase 4

Effectiveness of Varenicline: Testing Individual Differences

NCT01228175

COMPLETED NA

Effects of Sulfasalazine on BOLD Response to Alcohol Cues

NCT01312129

COMPLETED Phase 3

A New Pharmacotherapy for Alcohol Dependence: Olanzapine

NCT00746785

What is open in the The Mind Research Network pipeline

4 recruiting of 17 indexed (24% open); 9 completed (53%).

Phase mix: 2 late (III/IV) vs 5 early (I/II) (early-phase heavy).

Top condition: Alcohol Use Disorder (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The Mind Research Network: open-pipeline peers nationwide

Peers matched on 17 registered trials and 24% open enrollment, not the therapeutic-area sidebar.

The Mind Research Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1520253035 0%5%10%15%20%25% Total trials Recruiting share The Mind Research NetworkAchieve Life SciencesBioDelivery Sciences InternationalChugai PharmaceuticalConvaTecHALEONOncotherapeuticsScripps Whittier Diabetes InstituteMajor Extremity Trauma Research Consortium
The Mind Research Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The Mind Research Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 17 trials (± recruiting share)

Sponsors near 24% open enrollment (± trial volume)

What to do with this The Mind Research Network page

17 registered trials is a research-attention snapshot, not an endorsement of The Mind Research Network or any single study.

  • 4 of The Mind Research Network's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Alcohol Use Disorder is the condition The Mind Research Network studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Use Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The Mind Research Network pipeline card: 17 registered trials from official public datasets.Report a data error.